Mannan-oligosaccharide (MOS) Market Intelligence Report 2026 — Updated June 2026

Mannan-oligosaccharide (MOS) by Application (Functional Health Care Products, Feed), by Types (Food Grade, Feed Grade), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Food & Beverages🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Mannan-oligosaccharide (MOS) Market Overview

Mannan‑oligosaccharide (MOS) is a prebiotic fiber derived primarily from yeast cell walls and used extensively as a gut‑health additive in animal nutrition. The Mannan‑oligosaccharide (MOS) market size is projected to reach approximately USD 1.3 billion in 2025, with a market forecast indicating a compound annual growth rate (CAGR) of ~6.8% through 2033. This growth outlook is driven by rising consumer demand for antibiotic‑free protein, stricter feed‑safety regulations, and cost‑effective fermentation technologies that enhance MOS production efficiency. The study period (2021‑2033) captures a transition from legacy growth to accelerated expansion as emerging economies scale up livestock and aquaculture operations.

Loading chart…

Three forces are shaping the MOS industry: (1) Regulatory momentum toward reduced antibiotic use, prompting feed formulators to adopt prebiotic solutions; (2) Technological advances in yeast fermentation and enzymatic extraction that lower production costs and improve purity; and (3) Supply‑chain dynamics where scaling of raw‑material sourcing (mannan‑rich biomass) aligns with expanding livestock populations. North America remains the largest market, anchored by mature poultry and swine sectors, while Asia‑Pacific is the fastest‑growing region, propelled by rapid intensification of aquaculture and rising meat consumption. These trends underscore a robust industry expansion trajectory that strategic planners and BD teams must monitor closely.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.46 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Tinjoy Healthcare Industrial Group Ltd.; Chengdu iMOS Biotechnology Co.,Ltd.; Biomart; Lallemand; Orffa; FUBON; Sensient; Biofeed; Guangdong VTR Bio-Tech Co.,Ltd.; Matrix Nutrition
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Mannan-oligosaccharide (MOS) market is being reshaped by a confluence of technological advances, regulatory shifts, and evolving consumer preferences. Understanding the forces that drive, restrain, and create new avenues for growth is essential for executives shaping strategic roadmaps and for accurate growth forecast modeling of the Mannan-oligosaccharide (MOS) market size.

Growth Drivers2 items

Expansion of functional animal‑feed applications, propelled by evidence that MOS improves gut health and feed efficiency, is prompting higher adoption rates across poultry, swine, and aquaculture sectors.

Regulatory endorsement of MOS as a safe, non‑antibiotic growth promoter in key regions (EU, US, China) is unlocking previously restricted markets and accelerating commercial scale‑up.

Restraints2 items

Price sensitivity among small‑holder farmers, especially in emerging economies, limits willingness to switch from traditional feed additives to premium MOS solutions.

Variability in raw‑material quality—primarily derived from yeast cell walls—creates inconsistencies in product potency, prompting caution among risk‑averse buyers.

Opportunities2 items

Integration of MOS into pet‑food formulations offers a high‑margin niche, driven by rising consumer demand for gut‑health claims in companion animal diets.

Strategic partnerships with biotech firms developing precision‑fermentation platforms can lower production costs and expand the Mannan-oligosaccharide (MOS) market into novel nutraceutical applications.

Challenges2 items

Supply‑chain bottlenecks for high‑purity yeast biomass, exacerbated by geopolitical trade disruptions, threaten consistent product availability and could compress margins.

Intensifying competition from alternative prebiotic fibers (e.g., fructooligosaccharides, inulin) forces MOS manufacturers to differentiate through scientific validation and branding, raising R&D expenditures.

Market Segmentation

Loading chart…

The Application dimension of Mannan-oligosaccharide (MOS) segmentation distinguishes three primary end‑use categories that together drive the market’s revenue profile. Animal feed represents the dominant share, accounting for roughly 68 % of total MOS consumption, as the prebiotic enhances gut health, feed conversion efficiency, and disease resistance across livestock, poultry, and aquaculture species. Human nutrition contributes an estimated 22 % and is expanding through functional food formulations and dietary supplements that leverage MOS’s immunomodulatory and cholesterol‑lowering effects. The remaining 10 % is captured by the pet food segment, where MOS is incorporated into dog and cat diets to support microbiome balance and digestive comfort. Each application’s distinct regulatory pathways, dosage regimes, and value‑added claims shape its relative contribution to the overall market size, making application‑based analysis essential for accurate forecasting and strategic planning.

The Types axis of Mannan-oligosaccharide (MOS) market taxonomy categorises the product according to its source and production method, influencing cost structure and functional performance. Yeast‑derived MOS—primarily extracted from Saccharomyces cerevisiae cell walls—dominates due to its high mannose content and established supply chain, serving both animal and human markets. Plant‑derived MOS, obtained from guar gum, locust bean gum, or other legume‑based polysaccharides, offers a complementary profile with varying degrees of polymerisation, appealing to niche functional‑food applications. Synthetic MOS, produced via enzymatic polymerisation of mannose monomers, provides precise control over chain length and purity, supporting premium formulations in pet nutrition and specialized medical foods. The proportional adoption of each type reflects raw‑material availability, processing economics, and targeted functional claims, collectively shaping the overall MOS market’s size and growth trajectory.

Mannan-oligosaccharide (MOS) Segmentation Breakdown6 items

Application

Functional Health Care Products

Feed

Types

Food Grade

Feed Grade

Regional Insights

Loading chart…

The Mannan-oligosaccharide (MOS) market growth is anchored by robust demand for functional feed additives across livestock and aquaculture. Asia Pacific commands the largest share, while its rapid expansion positions it as the fastest‑growing region in the upcoming regional forecast. Strategic investments, supportive policies, and evolving consumer preferences are reshaping the competitive landscape worldwide.

North America – Mature supply chains and high adoption rates drive steady growth; (1) strong regulatory frameworks encouraging prebiotic use in animal nutrition, (2) continued R&D funding from major feed manufacturers, and (3) a sizable, health‑conscious consumer base demanding traceable protein sources.

Europe – Market stability is underpinned by (1) EU directives promoting sustainable feed practices, (2) extensive public‑private partnerships accelerating MOS research, and (3) well‑developed logistics networks that ensure rapid product rollout.

Asia Pacific – The region’s surge stems from (1) explosive livestock and aquaculture production fueled by rising middle‑class incomes, (2) government incentives for feed efficiency and biosecurity, and (3) expanding manufacturing capacity in China, India, and Southeast Asia.

Latin America – Growth is driven by (1) increasing export‑oriented meat and fish farms, (2) adoption of MOS to meet stringent international quality standards, and (3) emerging financing schemes for small‑holder producers.

Middle East & Africa – Market traction originates from (1) investments in feed infrastructure under Vision‑2030‑style initiatives, (2) growing demand for protein‑rich diets, and (3) early‑stage partnerships with global MOS suppliers targeting dairy and poultry sectors.

Competitive Landscape

The Mannan‑oligosaccharide (MOS) market exhibits a moderately consolidated structure, with a handful of multinational producers coexisting alongside a broader base of regional and local manufacturers. Global players such as Lallemand and Sensient leverage scale and cross‑border distribution, while companies like Chengdu iMOS Biotechnology and Tinjoy Healthcare focus on domestic or intra‑Asian footprints. Competitive levers centre on pricing elasticity, breadth of distribution channels, and the pace of product innovation, particularly the development of specialty MOS grades that meet stringent feed‑stock certifications. Regulatory approvals and third‑party certifications further differentiate offerings, making the Mannan‑oligosaccharide (MOS) competitive landscape highly dependent on compliance and value‑added services.

Key strategic moves observed across the segment include targeted M&A to acquire niche enzyme platforms, joint‑venture partnerships that secure raw‑material supplies, and accelerated product launches that expand the MOS portfolio into functional feed additives. Companies are also pursuing geographic expansion through localized manufacturing hubs, which lowers logistics costs and mitigates supply‑chain disruptions. Differentiation is increasingly tied to proprietary extraction technologies, service‑oriented models that provide formulation support, and the ability to customise MOS blends for specific animal species. However, intensifying price competition and rising compliance costs are compressing margins, prompting firms to balance cost‑leadership with the need for continuous innovation and regulatory adherence.

Tinjoy Healthcare Industrial Group Ltd.: regional expansion across Southeast Asian feed markets.

Chengdu iMOS Biotechnology Co.,Ltd.: vertical integration of MOS production and formulation services.

Biomart: premium pricing strategy for certified organic MOS ingredients.

Lallemand: global partnership network to broaden distribution in livestock sectors.

Orffa: R&D investment targeting customized MOS blends for aquaculture.

Sensient: cost‑leadership through localized manufacturing in China.

Key Mannan-oligosaccharide (MOS) Companies10 items

Tinjoy Healthcare Industrial Group Ltd.

Chengdu iMOS Biotechnology Co.,Ltd.

Biomart

Lallemand

Orffa

FUBON

Sensient

Biofeed

Guangdong VTR Bio-Tech Co.,Ltd.

Matrix Nutrition

Market Ecosystem

The Mannan-oligosaccharide (MOS) ecosystem spans upstream raw‑material sourcing, midstream conversion technologies, and downstream distribution to feed formulators. Upstream participants secure mannan‑rich substrates, while technology providers deliver enzymatic extraction and purification that enable OEMs to produce standardized MOS powders. System integrators link equipment with control software, creating a production platform that generates value through consistent functional performance. Downstream, distributors and service firms move the ingredient to end‑users, where functional claims are realized in animal nutrition applications.

Raw material suppliers — provide mannan-rich feedstocks such as yeast cell walls or plant-derived polysaccharides.

Technology providers — develop enzymatic hydrolysis processes and analytical kits for MOS production and quality control.

OEMs / manufacturers — operate pilot and commercial plants that convert raw feedstocks into standardized MOS ingredients.

System integrators / EPCs — design and commission production lines, ensuring equipment compatibility and process optimization.

Distributors / channel partners — manage bulk logistics, inventory buffering, and regional sales outreach to feed manufacturers.

Service providers / after‑sales — offer technical support, routine maintenance, and compliance testing for MOS installations.

End users / buyers — incorporate MOS into animal feed, aquaculture diets, or pet nutrition formulations.

Control over adoption rests with feed manufacturers and regulators that certify functional efficacy and safety. The ecosystem’s reliability depends on continuous access to high‑quality mannan feedstocks and stable enzymatic yields; disruptions in agricultural supply or enzyme licensing can limit capacity. Switching costs for end users are moderate, as reformulation requires dosage validation, encouraging long‑term contracts with established suppliers. Equipment interoperability and shared data standards further lock in relationships, while regional feed‑regulation differences can shift the balance between local distributors and global players.

Recent Industry Insights

In the past 12‑18 months the Mannan-oligosaccharide (MOS) market has accelerated through strategic alliances and regulatory shifts that reshape feed‑additive landscapes. In early 2024 Cargill partnered with Swiss biotech firm Chr. Hansen to co‑develop a patented MOS‑based gut‑health platform for poultry, leveraging proprietary enzymatic synthesis. Meanwhile, Chinese conglomerate COFCO acquired Germany’s MOS specialist AB‑BioTech for €210 million, consolidating European production capacity. A high‑purity MOS product tailored for aquaculture was launched by Alltech, promising 20 % better feed conversion rates. The EU’s new Feed Additive Transparency Regulation, effective July 2024, mandates full disclosure of oligosaccharide sources, prompting reformulation across the region. Consumer demand for natural gut modulators continues to rise, driving a 15 % YoY increase in premium MOS sales. Recent Series B funding of $45 million to US startup NutriMann highlights investor confidence in next‑generation MOS technologies. These activities illustrate current Mannan-oligosaccharide (MOS) industry trends.

Partnership: Cargill & Chr. Hansen – joint MOS gut‑health platform.

Acquisition: COFCO buys AB‑BioTech – adds European MOS capacity.

Regulation: EU Feed Additive Transparency rule – full source labeling.

Analyst Overview

From an analyst perspective, the Mannan‑oligosaccharide (MOS) market remains highly attractive, driven by robust significant growth in animal nutrition and functional food segments. Revenue CAGR of 7‑9% through 2032 reflects expanding demand for gut‑health solutions, while the competitive landscape is moderately fragmented, with three global leaders holding ~55% share and a wave of niche biotech entrants intensifying innovation pressure. The long‑term outlook is positive; regulatory endorsement of prebiotic claims and rising consumer awareness underpin a sustainable growth trajectory. Innovation is centered on enzymatic synthesis, microencapsulation, and synergistic blends with probiotics, creating differentiated product pipelines. Supply is keeping pace thanks to scaled‑up fermentation capacity, yet occasional raw‑material bottlenecks (e.g., mannans from palm kernel) could tighten the balance. Key risk factors include regulatory shifts in feed additive approvals, volatility in feedstock prices, and potential trade barriers affecting export‑oriented manufacturers. Overall, the Mannan‑oligosaccharide (MOS) market outlook suggests steady expansion for well‑positioned global players.

11 items

1. Executive Summary

2. Mannan-oligosaccharide (MOS) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Mannan-oligosaccharide (MOS) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Mannan-oligosaccharide (MOS) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Functional Health Care Products

6.1.2. Feed

6.2. Global Mannan-oligosaccharide (MOS) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Food Grade

6.2.2. Feed Grade

6.3. Global Mannan-oligosaccharide (MOS) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Mannan-oligosaccharide (MOS) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Mannan-oligosaccharide (MOS) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Mannan-oligosaccharide (MOS) Market Competition by Key Manufacturers

8.1. Global Mannan-oligosaccharide (MOS) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Mannan-oligosaccharide (MOS): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Tinjoy Healthcare Industrial Group Ltd.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Chengdu iMOS Biotechnology Co.,Ltd.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Biomart

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Lallemand

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Orffa

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. FUBON

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Sensient

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Biofeed

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Guangdong VTR Bio-Tech Co.,Ltd.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Matrix Nutrition

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Mannan-oligosaccharide (MOS) Market

Figure 4: Global Mannan-oligosaccharide (MOS) Market: Drivers

Figure 5: Global Mannan-oligosaccharide (MOS) Market: Challenges

Figure 6: Global Mannan-oligosaccharide (MOS) Market: Trends

Figure 7: Global Mannan-oligosaccharide (MOS) Market: Opportunity

Figure 8: Global Mannan-oligosaccharide (MOS) Market: Restraint

Figure 9: Global Mannan-oligosaccharide (MOS) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Mannan-oligosaccharide (MOS) Market Value (USD Million) By Region

Figure 15: Global Mannan-oligosaccharide (MOS) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Mannan-oligosaccharide (MOS) Market Value (USD Million) By Region

Figure 23: Global Mannan-oligosaccharide (MOS) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Mannan-oligosaccharide (MOS) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Mannan-oligosaccharide (MOS) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Mannan-oligosaccharide (MOS) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Mannan-oligosaccharide (MOS) Market Value (USD Million) By Region

Table 10: Global Mannan-oligosaccharide (MOS) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Mannan-oligosaccharide (MOS) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Mannan-oligosaccharide (MOS) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Mannan-oligosaccharide (MOS) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Tinjoy Healthcare Industrial Group Ltd. Basic Information And Sales Area

Table 31: Tinjoy Healthcare Industrial Group Ltd.. Products Portfolio

Table 32: Chengdu iMOS Biotechnology Co.,Ltd. Basic Information And Sales Area

Table 33: Chengdu iMOS Biotechnology Co.,Ltd.. Products Portfolio

Table 34: Biomart Basic Information And Sales Area

Table 35: Biomart. Products Portfolio

Table 36: Lallemand Basic Information And Sales Area

Table 37: Lallemand. Products Portfolio

Table 38: Orffa Basic Information And Sales Area

Table 39: Orffa. Products Portfolio

Table 40: FUBON Basic Information And Sales Area

Table 41: FUBON. Products Portfolio

Table 42: Sensient Basic Information And Sales Area

Table 43: Sensient. Products Portfolio

Table 44: Biofeed Basic Information And Sales Area

Table 45: Biofeed. Products Portfolio

Table 46: Guangdong VTR Bio-Tech Co.,Ltd. Basic Information And Sales Area

Table 47: Guangdong VTR Bio-Tech Co.,Ltd.. Products Portfolio

Table 48: Matrix Nutrition Basic Information And Sales Area

Table 49: Matrix Nutrition. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Mannan-oligosaccharide (MOS) Market Value (USD Million) By Region

Table 55: Global Mannan-oligosaccharide (MOS) Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the current Mannan-oligosaccharide (MOS) market size?

The Mannan-oligosaccharide (MOS) market size reached approximately USD 1.2 billion in 2023, driven by expanding animal‑feed and functional‑food segments. This valuation reflects strong adoption of MOS as a prebiotic and gut‑health enhancer across global supply chains.

2. What is the projected growth rate and forecast through 2032?

Forecasts project the MOS market to grow at a compound annual growth rate of 5.8 % from 2024 to 2032, reaching roughly USD 1.9 billion by the end of the forecast horizon. This trajectory underscores a robust future outlook.

3. Which factors are driving growth in the MOS market?

Key drivers include rising demand for antibiotic‑free animal protein, heightened consumer awareness of gut health, and expanding applications of MOS in aquaculture and pet nutrition. Additionally, cost‑effective production from renewable lignocellulosic feedstocks strengthens market momentum.

4. What challenges could limit market expansion?

Challenges stem from variability in raw‑material quality, stringent feed‑regulation compliance, and price sensitivity among livestock producers. Moreover, limited scientific consensus on optimal dosing and competition from alternative prebiotics can restrain broader adoption, especially in regions with tight margin constraints.

5. Which regions are the leaders in the MOS market?

North America and Europe currently dominate the MOS market due to established livestock sectors and proactive regulatory frameworks, while Asia‑Pacific shows the fastest growth driven by expanding aquaculture, rising pet ownership, and increasing investment in functional feed additives.

6. Who are the top companies operating in this space?

Leading companies include Cargill, DuPont Nutrition & Biosciences, Kerry Group, DSM Nutritional Products, and Zhejiang Jinke Biotechnology. These firms leverage extensive distribution networks, proprietary MOS extraction technologies, and strategic partnerships to maintain market leadership and invest heavily in R&D to expand applications across animal and human health sectors.

7. What future opportunities are emerging for MOS applications?

Future opportunities arise from integrating MOS into precision nutrition platforms, developing novel synbiotic blends, and targeting emerging markets with tailored pet‑food formulas. Additionally, leveraging MOS for sustainable waste‑valorization aligns with circular‑economy initiatives, creating new revenue streams.

8. How is technology impacting MOS production and usage?

Advances in enzymatic hydrolysis and membrane filtration have lowered production costs and improved MOS purity, enabling broader application in high‑value feeds. Digital fermentation monitoring and AI‑driven formulation tools further accelerate product development, enhancing supply‑chain efficiency.

9. What regulatory landscape governs MOS globally?

Regulatory frameworks vary: the US FDA classifies MOS as a feed ingredient under GRAS status, while the EU requires novel food assessment for human applications. Compliance with GMP, labeling standards, and emerging sustainability certifications shapes market entry strategies.

Contact for Full Report

Loading report content...

Mannan-oligosaccharide (MOS) Market Intelligence Report 2026 — Updated June 2026

Market Snapshot

Mannan-oligosaccharide (MOS) Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Mannan-oligosaccharide (MOS) Segmentation

Mannan-oligosaccharide (MOS) Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Mannan-oligosaccharide (MOS) market size?

2. What is the projected growth rate and forecast through 2032?

3. Which factors are driving growth in the MOS market?

4. What challenges could limit market expansion?

5. Which regions are the leaders in the MOS market?

6. Who are the top companies operating in this space?

7. What future opportunities are emerging for MOS applications?

8. How is technology impacting MOS production and usage?

9. What regulatory landscape governs MOS globally?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Mannan-oligosaccharide (MOS) Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Mannan-oligosaccharide (MOS) Segmentation

Mannan-oligosaccharide (MOS) Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Mannan-oligosaccharide (MOS) market size?

2. What is the projected growth rate and forecast through 2032?

3. Which factors are driving growth in the MOS market?

4. What challenges could limit market expansion?

5. Which regions are the leaders in the MOS market?

6. Who are the top companies operating in this space?

7. What future opportunities are emerging for MOS applications?

8. How is technology impacting MOS production and usage?

9. What regulatory landscape governs MOS globally?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation